The Mechanism Study on Histone Acetylation Activating Glioblastoma-derived Neurotrophic Factor Transcription

WANG Jian-cun, QUAN Xing-yun, PENG Ding-ting, HU Guan-cheng

Abstract

To study the regulation role and mechanism of protein acetylation on the expression of glioblastoma-derived neurotrophic factor (GDNF) in human glioma.  Methods  Six normal brain tissue samples, six low-grade glioma brain tissue (LG-glioma), and six high-grade glioma brain tissue (HG-glioma) were collected for study. Human glioma U251 cells were treated with histone acetylase inhibitor and histone deacetylase inhibition. The mRNA level of GDNF in glioma and normal controls was detected by Real-time PCR. H3K9 acetylation level of cAMP-response element binding protein (CREB) binding region on GDNF promoter and the ability of CREB combining to GDNF promoter were detected by ChIP-PCR. The effects of histone acetylase and deacetylase inhibitors on transcription factor binding ability and GDNF expression were detected.  Results  The mRNA level of GDNF in HG-glioma was significantly higher than those in normal brain tissue and LG-glioma (P < 0.01). The H3K9 acetylation level of GDNF promoter region in the glioma was increased compared to that in the normal brain tissue (P < 0.01), and the acetylation level in CREB-binding region on the GDNF promoter was higher than that in the non-CREB-binding region (P < 0.01). The binding activity of CREB and GDNF promoter in HG-glioma was higher than those in normal brain tissue and LG-glioma (P < 0.05). After treatment of U251 cells with histone acetyltransferase inhibition, the level of acetylation in CREB-binding region on GDNF promoter, the binding activity of CREB and GDNF promoter was decreased, and GDNF transcription and expression were down-regulated, while histone deacetylase inhibitors had the opposite effect (P < 0.01).  Conclusion  Histone acetylation promotes the transcription expression of GDNF in glioma by promoting the binding of transcription factor CREB to the promoter region of GDNF gene.

 

Keywords: Glioma, GDNF, Histone acetylation, Transcriptional factor

 

Full Text:

PDF


References


BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global Cancer Statistics 2018;Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin,2018,68(6) ;394-424.

TAYLOR L P. Diagnosis, treatment, and prognosis of glioma; five new things. Neurology, 2010, 75 ( 18S1 ); S28- S32.

LOUIS D N, PERRY A, REIFENBERGER G, et al. The 2016 World Health Organization classification of tumors of the central nervous system; a summary. Acta Neuropathol, 2016,131(6);803-820.

STLJPP R, HEGI M E, GORLIA T. et al. CENTRIC study team cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study) :a multicentre, randomised, open-label. phase 3 trial. Lancet Oncol,2014,15( 10); 1100-1108.

BAECKER P A, LEE W H, VERITY A N, et al. Characterization of a promoter for the human glial cell line- derived neurotrophic factor gene. Brain Res Mol Brain Res, 1999,69(2):209-222.

QU Г) W, LIY Y. WANG L, el at. Glial cell line-derived neurotrophic factor promotes proliferation of neuroglioma cells by up-regulation of cyclins PCNA and Ki-67. Eur Rev Med Pharmacol Sci,2015 ,19( 11):2070-2075.

KU M C, WOLF S A, RESPONDEK D, et al. GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis. Acta Neuropathob2013 .125(4) :609-620.

SAURA С A, CARDINAUX J R. Emerging roles of CREB- Regulated transcription coactivators in brain physiology and pathology. Trends Neurosci,2017 ,40( 12) ;720-733.

ALAREJOSJ Y, MONTMINY M. CREB and the CRTC coactivators; sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol.2011,12(3): 141-151.

MAYR B, MONTMINY M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol,2001,2(8) ;599-609.

HISAOKAK, MAEDA N, TSUCHIOKA M. et al. Antidepressants induce acute CREB phosphorylation and CRE-mediated gene expression in glial cells; a possible contribution to GDNF production. Brain Res.2008,1196; 53- 58[2019-02-l 1]. https://doi. org/10. 1016/j. brainres. 2007. 12.019.

YU Z Q, ZHANG В L, N1 H B, et al. Hyperacetylation of histone H3K9 involved in the promotion of abnormally high transcription of the gdnf gene in glioma cells. Mol Neurobiol, 2014,50(3):914-922.

ZHANG В L, N1 H B, LIU, et al. Egr-1 participates in abnormally high GDNF gene transcription mediated by histone hyperacetylation in glioma cells. Biochim Biophys Acta,2014,1839(11);1161-1169.

AYANLAJA A A, ZHANG B, JI G. et al. The reversible effects of glial cell line-derived neurotrophic factor (GDNF) in the human brain. Semin Cancer Biol. 2018» 53: 212-222 [ 2019-02-12 ]. https;//www. sciencedirect. com/science/article/pii/S1044579X18300427. https://doi. org,/10. 1016/j. semcancer. 2018. 07. 005.

ZHANG В L, DONG F L, GUO T W. et al. MiRNAs mediate GDNF-induced proliferation and migration of glioma cells. Cell Physiol Biochem.2017,44(5) ; 1923-1938.

KU M C, WOLF S A. RESPONDER D. et al. GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis. Acta Neuropathol.2013 .125(4):609-620.

SONG H. MOON A. Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and p38 МАРК signaling pathways. Neurosci Res,2006,56( 1) :29-38.

фмшш£.2015,53(35);1-4. YANG S F. LEE W J, TAN P. et al. Upregulation of miR- 328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas. Oncotargeb2015.6(5) :2736-2753.

AMAR S, SMITH L. FIELDS GB. Matrix metalloproteinase collagenolysis in health and disease. Biochim Biophys Acta Mol Cell Res, 2017, 1864 ( 11 Pt A): 1940-1951.


Refbacks

  • There are currently no refbacks.